|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Radius Health, Inc.
| | | Phone: | (617) 551-4700 | Fax: | (617) 551-4701 | Year Established: | 2003 | Ticker: | RDUS | Exchange: | NASDAQ | Main Contact: | Jesper Høiland, President & CEO | | Other Contacts: | Joseph Kelly, Senior VP, Sales and Marketing Brent Hatzis-Schoch, Senior VP & General Counsel Lauren Gallagher, VP, Finance Gary Hattersley, Ph.D., CSO Lorraine A. Fitzpatrick, Ph.D., Senior VP & CMO Jose (Pepe) Carmona, Senior VP & CFO Chhaya Shah, Senior VP, Technical Operations
| | Company Description | Radius is a leading company developing a new generation of drug therapies for osteoporosis and women’s health. BA058, Radius’ novel, proprietary analog of PTHrP (parathyroid hormone-related protein), is in clinical development as a treatment for osteoporosis in two delivery options: BA058 Injection is a subcutaneous injection form in Phase 3 clinical study; and the BA058 Microneedle Patch, currently in Phase 1 study, is a short wear-time, transdermal form based on a microneedle technology from 3M Drug Delivery Systems that is intended to promote improved patient compliance and drive an expansion of the osteoporosis market. The company has a pipeline of additional drug candidate programs in earlier stages of development. | |
|
|
|
|
|